title: Levosimendan for bridging in a pediatric patient with Alström syndrome awaiting heart-lung transplantation.
authors.forename: Marc-Phillip
authors.initials: MP
authors.lastname: Hitz
authors.forename: Harald
authors.initials: H
authors.lastname: Bertram
authors.forename: Harald
authors.initials: H
authors.lastname: Köditz
authors.forename: Heidi
authors.initials: H
authors.lastname: Görler
authors.forename: Christoph M
authors.initials: CM
authors.lastname: Happel
authors.forename: Armin
authors.initials: A
authors.lastname: Wessel
authors.forename: T Mesud
authors.initials: TM
authors.lastname: Yelbuz
mesh_terms: D000015:Abnormalities, Multiple / Q000188:drug therapy* / Q000235:genetics / Q000601:surgery; D000293:Adolescent; D002311:Cardiomyopathy, Dilated / Q000188:drug therapy* / Q000235:genetics / Q000601:surgery; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D018797:Cell Cycle Proteins; D016041:Heart-Lung Transplantation; D006801:Humans; D006835:Hydrazones / Q000627:therapeutic use*; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000235:genetics / Q000601:surgery; D008297:Male; D011506:Proteins; D011724:Pyridazines / Q000627:therapeutic use*; D000077464:Simendan; D013577:Syndrome; D016896:Treatment Outcome; D014850:Waiting Lists
chemical_list: C490729:ALMS1 protein, human; D002316:Cardiotonic Agents; D018797:Cell Cycle Proteins; D006835:Hydrazones; D011506:Proteins; D011724:Pyridazines; D000077464:Simendan